Literature DB >> 17085982

Pharmacist-led cardiac risk reduction model.

Tracey H Taveira1, Wen-Chih Wu, Oanh J Martin, Mark D Schleinitz, Peter Friedmann, Satish C Sharma.   

Abstract

The Cardiovascular Risk Reduction Clinic (CRRC) is a pharmacist-coordinated care model that incorporates the 4 major modifiable risk factors into a single treatment program. The authors aimed to assess the effectiveness of the CRRC model by comparing the Framingham point score before and after CRRC intervention. Retrospective data between 2001 and 2002 were analyzed for 375 veterans (age 65+/-10 years) with diabetes (88.8%) or coronary artery disease (44%) referred to the CRRC for intensive cardiac risk management. Total Framingham point score decreased from 14.5 at baseline to 13.6 after CRRC intervention (mean change 0.9+/-0.3). When considering only the patients not at target goals at baseline (n=200), significant improvements in guideline adherence was observed in low-density lipoprotein cholesterol, systolic blood pressure, hemoglobin A1c, and smoking. The CRRC model reduces the risk of cardiovascular events as assessed by Framingham point score in patients with established coronary artery disease and/or diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085982     DOI: 10.1111/j.1520-037x.2006.05339.x

Source DB:  PubMed          Journal:  Prev Cardiol        ISSN: 1520-037X


  13 in total

1.  Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Authors:  Barry L Carter; Barcey Levy; Brian Gryzlak; Yinghui Xu; Elizabeth Chrischilles; Jeffrey Dawson; Mark Vander Weg; Alan Christensen; Paul James; Linnea Polgreen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

Review 2.  Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.

Authors:  Greg Weeks; Johnson George; Katie Maclure; Derek Stewart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

Review 3.  The role of home blood pressure telemonitoring in managing hypertensive populations.

Authors:  Leah L Zullig; S Dee Melnyk; Karen Goldstein; Ryan J Shaw; Hayden B Bosworth
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

4.  A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.

Authors:  Barry L Carter; Christopher S Coffey; Elizabeth A Chrischilles; Gail Ardery; Dixie Ecklund; Brian Gryzlak; Mark W Vander Weg; Paul A James; Alan J Christensen; Christopher P Parker; Tyler Gums; Rachel J Finkelstein; Liz Uribe; Linnea A Polgreen
Journal:  Pharmacotherapy       Date:  2015-06-25       Impact factor: 4.705

5.  Collaborative Cardiovascular Risk Reduction in Primary Care II (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors.

Authors:  Erin M Yakiwchuk; Derek Jorgenson; Kerry Mansell; Tessa Laubscher; Marlys Lebras; David F Blackburn
Journal:  Can Pharm J (Ott)       Date:  2013-09

6.  A centralized cardiovascular risk service to improve guideline adherence in private primary care offices.

Authors:  Barry L Carter; Barcey T Levy; Brian Gryzlak; Elizabeth A Chrischilles; Mark W Vander Weg; Alan J Christensen; Paul A James; Carol A Moss; Christopher P Parker; Tyler Gums; Rachel J Finkelstein; Yinghui Xu; Jeffrey D Dawson; Linnea A Polgreen
Journal:  Contemp Clin Trials       Date:  2015-05-04       Impact factor: 2.226

7.  The association between C-reactive protein levels and insulin therapy in obese vs nonobese veterans with type 2 diabetes mellitus.

Authors:  Sameed Ahmed M Khatana; Tracey H Taveira; Andrea G Dooley; Wen-Chih Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-06       Impact factor: 3.738

8.  A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial.

Authors:  Beate H Garcia; Trude Giverhaug; June U Høgli; Frode Skjold; Lars Småbrekke
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

9.  A pharmacist-led follow-up program for patients with coronary heart disease in North Norway--a qualitative study exploring patient experiences.

Authors:  Beate Hennie Garcia; Sissel Lisa Storli; Lars Småbrekke
Journal:  BMC Res Notes       Date:  2014-03-29

10.  Effectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depression.

Authors:  Paul A Pirraglia; Tracey H Taveira; Lisa B Cohen; Wen-Chih Wu
Journal:  Prev Chronic Dis       Date:  2008-09-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.